Many rapid tests rely on fluorescence detection using a lens precisely aligned to a CMOS image sensor. Here, the field-of-view, depth-of-field, and lens f-number are crucial to achieving the required performance. The specification and design of the fluorescence excitation and emission filters are also key to the device performance. A common problem in fluorescence detection is an angular mismatch, leading to a bleedthrough of light, which degrades the system’s signal-to-noise ratio. Recognizing these challenges, the Gray Optics team designed the diagnostic device’s precision optical components for manufacturing at scale.
Gray Optics is already planning for significant growth in staff and facility space in 2021 to advance imaging technologies that build on their core capabilities: product development for biomedical and industrial applications through rapid prototyping, optical engineering, precision optical assembly and alignment, and custom test development.
For more information, please visit grayoptics.com.
Source: Gray Optics press release via PRWeb – November 13, 2020